Atlas Trials

Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study

Clinical trial NCT05131646 · COMPLETED

Trial details

NCT number
NCT05131646
Sponsor
Clearside Biomedical, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Neovascular Age-related Macular Degeneration
Start date
2021-10-08
Primary completion
2023-01-05
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.